RIGEL PHARMACEUTICALS, INC. Accounts Payable
RIGEL PHARMACEUTICALS, INC. (RIGL) had Accounts Payable of $4.01 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-04
- 2026-06-30: Accounts Payable, Current $4.01M.
- 2026-03-31: Accounts Payable, Current $4.49M.
- 2025-12-31: Accounts Payable, Current $7.19M.
- 2025-09-30: Accounts Payable, Current $3.85M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $4.01M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $4.49M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $7.19M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $3.85M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $7.29M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $3.95M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $3.34M 10-K · filed 2026-03-03 |
| 2024-09-30 | $3.81M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $6.13M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $9.28M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $7.14M 10-K · filed 2025-03-04 |
| 2023-09-30 | $8.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $5.24M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $6.29M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $22.51M 10-K · filed 2024-03-05 |
| 2022-09-30 | $2.72M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.15M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $4.61M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $3.79M 10-K · filed 2023-03-07 |
| 2021-09-30 | $3.14M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $1.69M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $5.09M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $3.71M 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.28M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.41M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $2.21M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $4.15M 10-K · filed 2021-03-02 |
| 2019-09-30 | $2.66M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $3.78M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.18M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $6.39M 10-K · filed 2020-02-27 |
| 2018-09-30 | $2.64M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $3.34M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $2.62M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $2.64M 10-K · filed 2019-02-28 |
| 2017-09-30 | $2.19M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $2.07M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $1.18M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $5.56M 10-K · filed 2018-03-06 |
| 2016-09-30 | $1.52M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $1.51M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $2.42M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $2.76M 10-K · filed 2017-03-07 |
| 2015-09-30 | $689.00K 10-Q · filed 2015-11-03 |
| 2015-06-30 | $1.10M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $1.14M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $1.61M 10-K · filed 2016-03-08 |
| 2014-09-30 | $1.02M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $1.90M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $1.16M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $3.90M 10-K · filed 2015-03-03 |
| 2013-09-30 | $1.02M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $2.12M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $2.14M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $1.70M 10-K · filed 2014-03-04 |
| 2012-09-30 | $1.39M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $1.91M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $1.92M 10-Q · filed 2012-05-01 |
| 2011-12-31 | $1.56M 10-K · filed 2013-03-05 |
| 2011-09-30 | $1.27M 10-Q · filed 2011-11-01 |
| 2011-06-30 | $1.46M 10-Q · filed 2011-08-02 |
| 2010-12-31 | $1.40M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |